Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Genotype 4”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT00662220
What this trial is testing

High-dose Ribavirin in Treatment of Chronic Hepatitis C Genotype 1 or 4

Who this might be right for
Chronic Hepatitis C
Foundation for Liver Research 110
Not applicableUnknownNCT01758939
What this trial is testing

Predictors of Response to Combined Pegylated Interferon and Ribavirin in Chronic Hepatitis C Infected Egyptian Patients

Who this might be right for
Hepatitis C, Chronic
Cairo University 100,000
Testing effectiveness (Phase 2)Study completedNCT04387539
What this trial is testing

ٍٍSofosbuvir/Simeprevir/Daclatasvir/Ribavirin and HCV Genotype 4-infected Egyptian Experienced Participants

Who this might be right for
Chronic Hepatitis C Virus Infection
Beni-Suef University 94
Testing effectiveness (Phase 2)Study completedNCT01685203
What this trial is testing

Evaluate the Safety and Effect of Co-administration of ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Adults With Chronic Hepatitis C Virus Infection

Who this might be right for
Hepatitis C, Chronic
AbbVie (prior sponsor, Abbott) 316
Testing effectiveness (Phase 2)Study completedNCT01439373
What this trial is testing

Safety, Antiviral Activity, and Pharmacokinetics of GSK2336805 With Peginterferon and Ribavirin in Chronic Hepatitis C Subjects

Who this might be right for
Hepatitis C, Chronic
GlaxoSmithKline 16
Post-approval studies (Phase 4)Study completedNCT00356486
What this trial is testing

Viral Kinetics of Treatment With Peginterferon Alpha-2a, Ribavirin and Epoetin β in Patients Coinfected HCV/HIV

Who this might be right for
HIV Infections
Germans Trias i Pujol Hospital 74
Testing effectiveness (Phase 2)Study completedNCT00759200
What this trial is testing

Safety and Efficacy of Albumin Interferon Administered Every 4 Weeks in Genotype 2/3 Hepatitis C Patients

Who this might be right for
Chronic Hepatitis C
Novartis 525
Testing effectiveness (Phase 2)Study completedNCT02081079
What this trial is testing

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination in Treatment-Naive and Treatment-Experienced Subjects With Chronic Genotype 4 or 5 HCV Infection

Who this might be right for
Chronic Genotype 4 HCVChronic Genotype 5 HCV
Gilead Sciences 85
Not applicableStudy completedNCT01054742
What this trial is testing

Observational Study of Patients With Chronic Hepatitis C Virus (HCV) Infected With HCV Genotype 1 Low Virus Load (LVL 1) and Effect of PegIntron Plus Rebetol Treatment (Study P04793 Part 2)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 2
Post-approval studies (Phase 4)Ended earlyNCT03797066
What this trial is testing

ATTIC - Access To Treat in the Community

Who this might be right for
Hepatitis C, Chronic
King's College Hospital NHS Trust 13
Testing effectiveness (Phase 2)Study completedNCT00704405
What this trial is testing

Safety and Efficacy of Vaniprevir (MK-7009) With Pegylated Interferon (Peg-IFN) and Ribavirin (RBV) in Treatment-Experienced Hepatitis C Virus (HCV) Participants (MK-7009-009)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 285
Large-scale testing (Phase 3)Study completedNCT03186313
What this trial is testing

Evaluate the Safety and Efficacy of the Combined Single Dose of Dactavira Plus Or Dactavira in Egyptian Adults With Chronic Genotype 4 HCV Infection

Who this might be right for
Hepatitis C
Egyptian Liver Hospital 72
Large-scale testing (Phase 3)Study completedNCT01448044
What this trial is testing

Phase III BMS-790052 Add-On to Peg-Interferon Alfa-2a and Ribavirin in Naive Hepatitis C

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 152
Testing effectiveness (Phase 2)Study completedNCT04391985
What this trial is testing

Sofosbuvir/Ombitasvir/Paritaprevir/ Ritonavir and Ribavirin for Hepatitis C Virus Genotype 4 Patients

Who this might be right for
Chronic Hepatitis C Virus Infection
Beni-Suef University 113
Testing effectiveness (Phase 2)Ended earlyNCT02956629
What this trial is testing

Efficacy and Safety of Uprifosbuvir (MK-3682) + Ruzasvir (MK-8408) in Treating Hepatitis C Virus Infection Genotypes 1-6 (MK-3682-041)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 282
Large-scale testing (Phase 3)Study completedNCT02250807
What this trial is testing

Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Subjects With Chronic Genotype 4 Hepatitis C Virus Infection

Who this might be right for
Chronic Hepatitis CGenotype 4 Chronic Hepatitis C
Janssen R&D Ireland 40
Testing effectiveness (Phase 2)Study completedNCT02593162
What this trial is testing

Faldaprevir, Ribavirin and TD-6450 in Participants With Genotype 4 Hepatitis C Virus Infection

Who this might be right for
Hepatitis C Viral InfectionChronic Hepatitis CHepatitis C (HCV)+1 more
Trek Therapeutics, PBC 16
Testing effectiveness (Phase 2)Study completedNCT01010646
What this trial is testing

Study Comparing the Tolerability and Viral Reduction of the Combination of IFN a-2b XL + Ribavirin Versus Peg IFN a-2b + Ribavirin in Patients With Chronic Hepatitis C, Genotype 1 or 4

Who this might be right for
Chronic Hepatitis C
ANRS, Emerging Infectious Diseases 84
Large-scale testing (Phase 3)WithdrawnNCT01797848
What this trial is testing

Efficacy and Safety Evaluation of a Treatment Consisting of Peg Interferon Alfa + Ribavirin + Daclatasvir in HCV Genotype 1 and 4 Treatment naïve Patients

Who this might be right for
Hepatitis C
Bristol-Myers Squibb
Testing effectiveness (Phase 2)Study completedNCT02243280
What this trial is testing

Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-administration of ABT-493 and ABT-530 With and Without Ribavirin in Subjects With HCV Genotype 1, 4, 5, and 6 Infection

Who this might be right for
Chronic Hepatitis CHepatitis C VirusHCV
AbbVie 174
Next Page